BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17570910)

  • 1. Pathways into receiving a prescription for diamorphine (heroin) for the treatment of opiate dependence in the United kingdom.
    Metrebian N; Mott J; Carnwath Z; Carnwath T; Stimson GV; Sell L
    Eur Addict Res; 2007; 13(3):144-7. PubMed ID: 17570910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients receiving a prescription for diamorphine (heroin) in the United Kingdom.
    Metrebian N; Carnwath Z; Mott J; Carnwath T; Stimson GV; Sell L
    Drug Alcohol Rev; 2006 Mar; 25(2):115-21. PubMed ID: 16627300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.
    Verthein U; Haasen C; Reimer J
    Subst Use Misuse; 2011; 46(8):980-91. PubMed ID: 21235340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heroin-assisted treatment in Switzerland: a case study in policy change.
    Uchtenhagen A
    Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom.
    Metrebian N; Carnwath T; Stimson GV; Storz T
    Addiction; 2002 Sep; 97(9):1155-61. PubMed ID: 12199831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription of diamorphine, dipipanone and cocaine in England and Wales.
    Sell L; Farrell M; Robson P
    Drug Alcohol Rev; 1997 Sep; 16(3):221-6. PubMed ID: 16203431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From illegal poison to legal medicine: a qualitative research in a heroin-prescription trial in Spain.
    Romo N; Poo M; Ballesta R;
    Drug Alcohol Rev; 2009 Mar; 28(2):186-95. PubMed ID: 19320704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients prescribed injectable heroin or methadone -their opinions and experiences of treatment.
    Sell L; Zador D
    Addiction; 2004 Apr; 99(4):442-9. PubMed ID: 15049744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heroin prescription in Europe: heroin treatment is a pragmatic way of reducing the risks associated with addiction.
    Prescrire Int; 2003 Dec; 12(68):235-6. PubMed ID: 14986702
    [No Abstract]   [Full Text] [Related]  

  • 10. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diamorphine treatment for opiate dependence: putative markers of concomitant heroin misuse.
    McLachlan-Troup N; Taylor GW; Trathen BC
    Addict Biol; 2001 Jul; 6(3):223-231. PubMed ID: 11900600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between prescribing and risk of opiate overdose among drug users in and out of maintenance treatment.
    Man LH; Best D; Gossop M; Stillwell G; Strang J
    Eur Addict Res; 2004; 10(1):35-40. PubMed ID: 14665804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of heroin-assisted treatment in Germany.
    Verthein U; Bonorden-Kleij K; Degkwitz P; Dilg C; Köhler WK; Passie T; Soyka M; Tanger S; Vogel M; Haasen C
    Addiction; 2008 Jun; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.
    Bond AJ; Reed KD; Beavan P; Strang J
    Drug Alcohol Rev; 2012 Jun; 31(4):492-8. PubMed ID: 21919979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is heroin-assisted treatment effective for patients with no previous maintenance treatment? Results from a German randomised controlled trial.
    Haasen C; Verthein U; Eiroa-Orosa FJ; Schäfer I; Reimer J
    Eur Addict Res; 2010; 16(3):124-30. PubMed ID: 20424456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Key Extended Entry Program (KEEP): from the community side of the bridge.
    Fallon BM
    Mt Sinai J Med; 2001 Jan; 68(1):21-7. PubMed ID: 11135502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud.
    Pelet A; Doll S; Huissoud T; Resplendino J; Besson J; Favrat B
    Am J Drug Alcohol Abuse; 2007; 33(5):665-74. PubMed ID: 17891659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.